Open prospective multicenter trial with a new monophasic contraceptive combination containing gestodene
- 31 May 1991
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 43 (5) , 413-421
- https://doi.org/10.1016/0010-7824(91)90132-y
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparative studies of 30 μg ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and plateletsAmerican Journal of Obstetrics and Gynecology, 1990
- Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroidAmerican Journal of Obstetrics and Gynecology, 1990
- An epidemiologic survey of cardiovascular disease in women taking oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1990
- Gestodene: A novel synthetic progestin — characterization of binding to receptor and serum proteinsContraception, 1989
- Clinical aspects of three new progestogens: Desogestrel, gestodene, and norgestimateAmerican Journal of Obstetrics and Gynecology, 1989
- Effects of Two Triphasic Oral Contraceptives Containing Ethinylestradiol Plus Levonorgestrel or Gestodene on Blood Coagulation and FibrinolysisActa Obstetricia et Gynecologica Scandinavica, 1989
- Risks and mechanisms of cardiovascular events in users of oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1988
- Gestoden, an innovative progestogenContraception, 1988
- New progestogens in oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1987
- Progestogen potency in oral contraceptive pillsAmerican Journal of Obstetrics and Gynecology, 1987